Largest private funder of ovarian cancer research recognizes top researchers and community leaders NEW YORK — Today, Ovarian Cancer Research Alliance (OCRFA), the nation’s leading ovarian cancer research, advocacy and patient support… Read on
On September 7th, the FDA issued an important safety communication about tests marketed as ovarian cancer screening tests, including the ROCA Test developed by Abcodia Incorporated… Read on
Donna Karan, Kelly Ripa and Gabby Karan de Felice hosted Ovarian Cancer Research Alliance’s (OCRFA) 19th annual Super Saturday NY… Read on
Foodie Fast-Casual Brand Reaches Halfway Point in Its 200-Unit Growth Plan JACKSON, Miss… Read on
When Lori Newcomb first visited her doctor for abdominal pain, the last thing she expected to walk out with was a late-stage ovarian cancer diagnosis… Read on
FOR IMMEDIATE RELEASE May 17, 2016 Lisa Mauti lmauti@ocrfa.org 202-517-6410 Supreme Court Returns Zubik v… Read on
May 2, 2016 – Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-‐affiliated scientists… Read on
Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A… Read on
April 11, 2016 – Many members of the ovarian cancer community have been concerned about the results of GOG 252 clinical trial, which were released last month at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer… Read on
The Institute of Medicine (IOM) recently released a report commissioned by Congress, Ovarian Cancers: Evolving Paradigms in Research and Care. The report provides an in-depth look at the state of ovarian cancer in the United States… Read on
